What is the current treatment of PTLD after liver transplantation?
Dufour
Jean-François
JF
Department of Clinical Pharmacology, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland. jf.dufour@ikp.unibe.ch
Fey
Martin F
MF
D003131:Combined Modality Therapy; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome